Sylics was acquired by InnoSer. To see what’s new, read below or use the navigation bar to find the information you need.

    Preclinical Services Overview

    State-of-the-art methods for accelerating your drug development.

    Preclinical support to ultimately cure patients

    Founded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting the preclinical development of drugs. Our mission is to accelerate drug development by offering well-characterized and translational research models and innovative CRO services.

    Our Focus

    From target validation to preclinical stages of the development pipeline

    InnoSer actively guides and supports our customers with a variety of in vivo and in vitro methods backed by niche expertise and therapeutic knowledge.

    Our Pillars

    Quality in vitro and in vivo services to fit your project

    Drug Development Services

    Pharmacology and efficacy studies

    • PK/PD studies
    • Optimal dose determination studies
    • Non-GLP toxicology
    • Biocompatibiltiy studies
    • 2D/3D cell culture
      • Organoids


    • High content imaging
    • Live cell imaging
    • Bioluminescence imaging
    • Ultrasound
    • Confocal microscopy
    • Digital histopathology
    • Biomarker analysis
    • Flow cytometry
    Facility management

    • Contract breeding
    • Cryopreservation and rederivation
    • Cardiac surgery
    • Stereotactic injection
    • Implantation of tumors

    Customized service 

    • Medical device testing
    • Disease model development
    • Vaccine development

    Therapeutic Expertise

    Rare Disease

    • Polycystic Kidney Disease
    • Stxbp1 encephalopathy
    • Fragile X syndrome
    • Amyotrophic lateral sclerosis 
    • Duchenne Muscular Dystrophy
    • Vanishing white matter


    • In vitro cell lines & PDO bank 
    • In vivo CDX & PDX models
    • Orthotopic & syngeneic models
    • Humanized IC & IS models
    • Broad Immuno-oncology  readouts


    • In vitro & in vivo (behavioral) models
    • Central & peripheral system
    • Neurodegenerative diseases
    • Psychiatric conditions
    • Ageing

    Cardio-metabolic diseases

    • Ischemic heart disease
    • Hypertrophic heart disease
    • Diabetes type I & II
    • Liver inflammation & fibrosis

    Need more information?

    If you have any questions about how we can help accelerate your research,

    then let us know